Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment.

A maternal history of Graves' disease places the fetus at risk for thyrotoxicosis in utero via the placental transfer of thyroid-stimulating immunoglobulins. Methods for prediction of fetal hyperthyroidism are available, but are not widely used. Clinical assessment of fetal thyroid status by monitoring of fetal heart rate and growth may be inaccurate. This raises some uncertainty in the initial diagnosis of fetal thyrotoxicosis and complicates the assessment of fetal response to maternal propylthiouracil therapy. A case illustrating these pitfalls in the diagnosis and management of fetal hyperthyroidism is presented. The condition was correctly diagnosed, but treatment based on fetal heart rate resulted in biochemical hypothyroidism in the infant at birth. Current recommendations for diagnosis and treatment of fetal hyperthyroidism are reviewed along with recent developments in the field. A modified approach is proposed.

[1]  J. Mckenzie,et al.  Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. , 1992, Thyroid : official journal of the American Thyroid Association.

[2]  R. Clemons,et al.  The fetus in maternal hyperthyroidism. , 1992, Thyroid : official journal of the American Thyroid Association.

[3]  K. Nicolaides,et al.  Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. , 1991, The New England journal of medicine.

[4]  A. Madec,et al.  Anti TSH‐receptor antibodies in pregnant patients with autoimmune thyroid disorder , 1990, British journal of obstetrics and gynaecology.

[5]  Porreco Rp,et al.  Fetal blood sampling in the management of intrauterine thyrotoxicosis. , 1990 .

[6]  K. Wenstrom,et al.  PRENATAL DIAGNOSIS OF FETAL HYPERTHYROIDISM USING FUNIPUNCTURE , 1990, Obstetrics and gynecology.

[7]  C. Rodeck,et al.  MATURATION OF THYROID FUNCTION IN NORMAL HUMAN FOETUSES , 1989, Clinical Endocrinology.

[8]  C. Weiner.  The role of cordocentesis in fetal diagnosis. , 1988, Clinical obstetrics and gynecology.

[9]  Y. Iwatani,et al.  Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. , 1988, American journal of perinatology.

[10]  T. Momoi,et al.  Transient neonatal hyperthyroidism and maternal thyroid stimulating immunoglobulins. , 1988, Archives of disease in childhood.

[11]  K. Fujieda,et al.  TSH-RECEPTOR ANTIBODIES IN MOTHERS WITH GRAVES' DISEASE AND OUTCOME IN THEIR OFFSPRING , 1988, The Lancet.

[12]  J. Wit,et al.  Fetal treatment for thyrotoxicosis in non-thyrotoxic pregnant women. , 1988, Fetal therapy.

[13]  N. Ishikawa,et al.  Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. , 1986, The New England journal of medicine.

[14]  J. Konishi,et al.  Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment. , 1986, Acta endocrinologica.

[15]  J. Mckenzie,et al.  Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. , 1986, The Journal of clinical endocrinology and metabolism.

[16]  D. Cooper,et al.  Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. , 1986, The Journal of clinical endocrinology and metabolism.

[17]  G. Burrow.  The management of thyrotoxicosis in pregnancy. , 1985 .

[18]  K. Teramo,et al.  Prenatal diagnosis and treatment of fetal thyrotoxicosis. , 1984, American journal of obstetrics and gynecology.

[19]  R. Volpe,et al.  Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. , 1984, The American journal of medicine.

[20]  J. Mckenzie,et al.  Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.

[21]  L. Braverman,et al.  The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. , 1983, Endocrine reviews.

[22]  P. Larsen,et al.  Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. , 1981, The New England journal of medicine.

[23]  D. Daneman,et al.  Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. , 1980, The Journal of pediatrics.

[24]  J. Sack,et al.  Amniotic fluid 3,3',5'-triiodothyronine in the detection of congenital hypothyroidism. , 1980, The Journal of clinical endocrinology and metabolism.

[25]  C. Hobel,et al.  Thyroxine in human amniotic fluid. , 1975, The Journal of pediatrics.

[26]  D. Munro,et al.  Placental transmission of thyroid-stimulating immunoglobulins. , 1975, British medical journal.